Single-domain antibodies for biomedical applications

被引：56

作者：

Krah, Simon ^{[1
]}

Schroeter, Christian ^{[1
]}

Zielonka, Stefan ^{[2
]}

Empting, Martin ^{[3
]}

Valldorf, Bernhard ^{[2
]}

Kolmar, Harald ^{[2
]}

机构：

[1] Merck KGaA, Merck Serono, Prot Engn & Antibody Technol, Darmstadt, Germany

[2] Tech Univ Darmstadt, Inst Organ Chem & Biochem, Alarich Weiss Str 4, D-64287 Darmstadt, Germany

[3] Univ Saarland, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Drug Design & Optimizat, D-66123 Saarbrucken, Germany

来源：

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY | 2016年 / 38卷 / 01期

关键词：

VHH; heavy chain antibody; Antibody engineering; antibody fragment; single chain binding domain; IgNAR; SHARK IGNAR ANTIBODY; ANTIGEN RECEPTOR IGNAR; VARIABLE DOMAINS; BIOPHYSICAL PROPERTIES; AFFINITY MATURATION; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; SELECTION; FRAGMENTS; NANOBODY;

D O I：

10.3109/08923973.2015.1102934

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Single-domain antibodies are the smallest antigen-binding units of antibodies, consisting either only of one variable domain or one engineered constant domain that solely facilitates target binding. This class of antibody derivatives comprises naturally occurring variable domains derived from camelids and sharks as well as engineered human variable or constant antibody domains of the heavy or light chain. Because of their high affinity and specificity as well as stability, small size and benefit of multiple re-formatting opportunities, those molecules emerged as promising candidates for biomedical applications and some of these entities have already proven to be successful in clinical development.

引用

页码：21 / 28

页数：8

共 114 条

[61] Isolation of anti-toxin single domain antibodies from a semi-synthetic spiny dogfish shark display library [J].

Liu, Jinny L. ;

Anderson, George P. ;

Goldman, Ellen R. .

BMC BIOTECHNOLOGY, 2007, 7

[62] Selection of cholera toxin specific IgNAR single-domain antibodies from a naive shark library [J].

Liu, Jinny L. ;

Anderson, George P. ;

Delehanty, James B. ;

Baumann, Richard ;

Hayhurst, Andrew ;

Goldman, Ellen R. .

MOLECULAR IMMUNOLOGY, 2007, 44 (07) :1775-1783

[63] Affinity selection of a camelized V-H domain antibody inhibitor of hepatitis C virus NS3 protease [J].

Martin, F ;

Volpari, C ;

Steinkuhler, C ;

Dimasi, N ;

Brunetti, M ;

Biasiol, G ;

Altamura, S ;

Cortese, R ;

DeFrancesco, R ;

Sollazzo, M .

PROTEIN ENGINEERING, 1997, 10 (05) :607-614

[64] Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo [J].

Maussang, David ;

Mujic-Delic, Azra ;

Descamps, Francis J. ;

Stortelers, Catelijne ;

Vanlandschoot, Peter ;

Stigter-van Walsum, Marijke ;

Vischer, Henry F. ;

van Roy, Maarten ;

Vosjan, Maria ;

Gonzalez-Pajuelo, Maria ;

van Dongen, Guus A. M. S. ;

Merchiers, Pascal ;

van Rompaey, Philippe ;

Smit, Martine J. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (41) :29562-29572

[65] Generation and antitumor effects of an engineered and energized fusion protein VL-LDP-AE composed of single-domain antibody and lidamycin [J].

Miao QingFang ;

Shang BoYang ;

Ouyang ZhiGang ;

Liu XiaoYun ;

Zhen YongSu .

SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 2007, 50 (04) :447-456

[66] Immunological applications of single-domain llama recombinant antibodies isolated from a naive library [J].

Monegal, Ana ;

Ami, Diletta ;

Martinelli, Chiara ;

Huang, He ;

Aliprandi, Marisa ;

Capasso, Paola ;

Francavilla, Chiara ;

Ossolengo, Giuseppe ;

de Marco, Ario .

PROTEIN ENGINEERING DESIGN & SELECTION, 2009, 22 (04) :273-280

[67] Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following lntravitreal administration [J].

Mordenti, J ;

Cuthbertson, RA ;

Ferrara, N ;

Thomsen, K ;

Berleau, L ;

Licko, V ;

Allen, PC ;

Valverde, CR ;

Meng, YG ;

Fei, DTW ;

Fourre, KM ;

Ryan, AM .

TOXICOLOGIC PATHOLOGY, 1999, 27 (05) :536-544

[68] Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages [J].

Movahedi, Kiavash ;

Schoonooghe, Steve ;

Laoui, Damya ;

Houbracken, Isabelle ;

Waelput, Wim ;

Breckpot, Karine ;

Bouwens, Luc ;

Lahoutte, Tony ;

De Baetselier, Patrick ;

Raes, Geert ;

Devoogdt, Nick ;

Van Ginderachter, Jo A. .

CANCER RESEARCH, 2012, 72 (16) :4165-4177

[69] Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain [J].

Mueller, Mischa R. ;

Saunders, Kenneth ;

Grace, Christopher ;

Jin, Macy ;

Piche-Nicholas, Nicole ;

Steven, John ;

O'Dwyer, Ronan ;

Wu, Leeying ;

Khetemenee, Lam ;

Vugmeyster, Yulia ;

Hickling, Timothy P. ;

Tchistiakova, Lioudmila ;

Olland, Stephane ;

Gill, Davinder ;

Jensen, Allan ;

Barelle, Caroline J. .

MABS, 2012, 4 (06) :673-685

[70] Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1 [J].

Nuttall, SD ;

Humberstone, KS ;

Krishnan, UV ;

Carmichael, JA ;

Doughty, L ;

Hattarki, M ;

Coley, AM ;

Casey, JL ;

Anders, RF ;

Foley, M ;

Irving, RA ;

Hudson, PJ .

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2004, 55 (01) :187-197

← 2 3 4 5 6 7 8 9 10 11 →